Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dialkylcarbamoylchloride
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved
Sponsor : Essity
Deal Size : Undisclosed
Deal Type : Acquisition
Essity Acquires 75% of the Medical Solutions Company ABIGO Medical AB
Details : ABIGO Medical has leading innovations in advanced wound care that reduce the spread of bacteria without increasing resistance to antibiotics.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
February 27, 2020
Lead Product(s) : Dialkylcarbamoylchloride
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved
Sponsor : Essity
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?